OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SMLE56

Sinergi Multi Lestarindo PT Tbk

Specialty ChemicalsVerified

Sinergi Multi Lestarindo maintains a relatively strong liquidity position, with cash and equivalents of IDR 40,086,476,870 and a current ratio of 1.87, indicating the company can cover its short-term liabilities more than once over. However, the company's free cash flow is negative at IDR -4,016,498,650, and capital expenditures are significant at IDR -7,376,300,920, suggesting ongoing investment in operations. The debt-to-equity ratio of 0.45 indicates a moderate level of leverage, with long-term debt at IDR 48,806,201,460 and total equity at IDR 107,289,251,440. The company's profitability is weak, with a return on equity (ROE) of 0.24% and a return on assets (ROA) of 0.12%, both significantly below the typical performance of the specialty chemicals industry. Gross profit of IDR 56,470,418,370 and operating income of IDR 5,243,341,400 suggest limited margin expansion, with net income at only IDR 255,856,800. These figures indicate the company is struggling to convert revenue into profit effectively. Sinergi Multi Lestarindo's revenue is derived from three primary segments: food ingredients, personal care, and industrial chemicals. The company's exposure to these segments is not disclosed in detail, but the product breadth suggests a diversified approach. Geographically, the company is concentrated in Indonesia, with no disclosed international revenue, which may limit its growth potential and expose it to local economic and regulatory risks. The company's growth trajectory is uncertain, with no specific revenue outlook provided. However, the negative free cash flow and high capital expenditures suggest the company is investing in its operations, which could support future growth. The operating cash flow of IDR 8,501,927,600 indicates the company is generating some cash from operations, but it is not sufficient to cover capital expenditures. The company faces a medium liquidity risk, as its net cash position is negative after subtracting total debt. The risk of dilution is low, but the company's weak profitability and high capital expenditures could lead to future equity issuance if financing needs increase. No recent events or filings have been disclosed that would significantly impact the company's operations or financial position.

30-day price · SMLE-13.00 (-10.0%)
Low$106.00High$147.00Close$117.00As of13 May, 00:00 UTC
Profile
CompanySinergi Multi Lestarindo PT Tbk
TickerSMLE.JK
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Sinergi Multi Lestarindo PT Tbk (SMLE.JK) is an Indonesia-based specialty chemical supplier that distributes food ingredients, personal care products, and industrial chemicals, generating revenue through formulation solutions and product sales.

Classification. Sinergi Multi Lestarindo is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a confidence level of 0.92 based on verified market data.

Sinergi Multi Lestarindo maintains a relatively strong liquidity position, with cash and equivalents of IDR 40,086,476,870 and a current ratio of 1.87, indicating the company can cover its short-term liabilities more than once over. However, the company's free cash flow is negative at IDR -4,016,498,650, and capital expenditures are significant at IDR -7,376,300,920, suggesting ongoing investment in operations. The debt-to-equity ratio of 0.45 indicates a moderate level of leverage, with long-term debt at IDR 48,806,201,460 and total equity at IDR 107,289,251,440. The company's profitability is weak, with a return on equity (ROE) of 0.24% and a return on assets (ROA) of 0.12%, both significantly below the typical performance of the specialty chemicals industry. Gross profit of IDR 56,470,418,370 and operating income of IDR 5,243,341,400 suggest limited margin expansion, with net income at only IDR 255,856,800. These figures indicate the company is struggling to convert revenue into profit effectively. Sinergi Multi Lestarindo's revenue is derived from three primary segments: food ingredients, personal care, and industrial chemicals. The company's exposure to these segments is not disclosed in detail, but the product breadth suggests a diversified approach. Geographically, the company is concentrated in Indonesia, with no disclosed international revenue, which may limit its growth potential and expose it to local economic and regulatory risks. The company's growth trajectory is uncertain, with no specific revenue outlook provided. However, the negative free cash flow and high capital expenditures suggest the company is investing in its operations, which could support future growth. The operating cash flow of IDR 8,501,927,600 indicates the company is generating some cash from operations, but it is not sufficient to cover capital expenditures. The company faces a medium liquidity risk, as its net cash position is negative after subtracting total debt. The risk of dilution is low, but the company's weak profitability and high capital expenditures could lead to future equity issuance if financing needs increase. No recent events or filings have been disclosed that would significantly impact the company's operations or financial position.
Key takeaways
  • Sinergi Multi Lestarindo has a strong liquidity position but is generating negative free cash flow, indicating ongoing investment in operations.
  • The company's profitability is weak, with ROE and ROA significantly below industry norms.
  • Revenue is derived from three primary segments, with no detailed breakdown provided.
  • The company is concentrated in Indonesia, which may limit its growth potential and expose it to local economic and regulatory risks.
  • The company faces a medium liquidity risk and a low risk of dilution, but its financial performance suggests potential for future equity issuance.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue$219.02B
Gross profit$56.47B
Operating income$5.24B
Net income$255.9M
R&D
SG&A
D&A
SBC
Operating cash flow$8.50B
CapEx-$7.38B
Free cash flow-$4.02B
Total assets$205.70B
Total liabilities$98.41B
Total equity$107.29B
Cash & equivalents$40.09B
Long-term debt$48.81B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$107.29B
Net cash-$8.72B
Current ratio1.9
Debt/Equity0.5
ROA0.1%
ROE0.2%
Cash conversion33.2%
CapEx/Revenue-3.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricSMLEActivity
Op margin2.4%0.4% medp25 -8.0% · p75 16.0%above median
Net margin0.1%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin25.8%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity45.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 08:57 UTC#72991332
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 08:58 UTCJob: fbb9091d